Novavax Working with FDA For Authorization Of 2024-2025 COVID-19 Vaccine Formula, Expects Approval in Time for Peak Vaccination Season
Novavax Working with FDA For Authorization Of 2024-2025 COVID-19 Vaccine Formula, Expects Approval in Time for Peak Vaccination Season